通產麗星(002243.SZ)下屬擬以不超2000萬元參與競拍湘潭市一幅地塊
格隆匯2月5日丨通產麗星(002243.SZ)公佈,公司第四屆董事會第十八次會議於2020年2月5日以通訊方式召開。本次董事會會議通知已於2020年1月22以電子郵件、書面方式送達給全體董事、監事和高級管理人員。本次會議應到董事9人,實到董事9人。會議的內容以及召集、召開的方式、程序均符合《公司法》和《公司章程》的規定。經全體與會董事表決,一致通過以下決議:
同意下屬企業湖南力合創新發展有限公司自籌不超過人民幣2000萬元,參與競拍湘潭市公共資源交易中心掛牌編號為潭市高管公土網掛(2019)004號的土地使用權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.